SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001213900-24-029808
Filing Date
2024-04-03
Accepted
2024-04-03 16:01:52
Documents
1
Effectiveness Date
2024-04-03
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 12879
  Complete submission text file 0001213900-24-029808.txt   14039
Mailing Address THE CIRCLE 6 8058 ZURICH V8 CH-6370
Business Address THE CIRCLE 6 8058 ZURICH V8 CH-6370 41-41-618-80-00
NLS Pharmaceutics Ltd. (Filer) CIK: 0001783036 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-509559 | Film No.: 24818602
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)